The last decade witnessed a significant progress in understanding the biology and immunology of colorectal cancer alongside with the technical innovations in ra
Treatment of inflammatory bowel disease has significantlyimproved since the introduction of biologicalagents, such as infliximab, adalimumab, certolizumabpegol,
Hepatocellular carcinoma(HCC),the predominant form of adult liver malignancies,is a global health concern.Its dismal prognosis has prompted recent significant a